Clicky

Orthocell Ltd  (OCC)

Description: Orthocell Limited is a regenerative medicine company. The Company is engaged in the development and commercialization of cell therapies and related technologies. The Company's products include CelGro, a collagen medical device for soft tissue repair in use as an augment to rotator cuff repair, guided bone regeneration and repair of articular cartilage, and Autologous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon regeneration. CelGro is targeted on a range of orthopedic, reconstructive and surgical applications. Ortho-ATI is a treatment that uses a minimally invasive, non-surgical approach that uses each patient's own tendon derived stem cells to stimulate tendon regeneration and is delivered through ultrasound guided injection under local anesthetic. The Company's Autologous Chondrocyte Implantation (Ortho-ACI) offers treatment for symptomatic defects of the articulating cartilage of the joints, including the knee and ankle.


Keywords: Medicine Surgery Medical Device Stem Cell Ultrasound Regenerative Medicine Implant Sound Collagen Knee Plantation Tissue Engineering Cartilage Osteochondritis Dissecans Regenerative Surgical Applications Soft Tissue Repair Autologous Chondrocyte Implantation Rotator Cuff Repair Shoulder

Home Page: orthocell.com

OCC Technical Analysis

Building 191
Murdoch, WA 6150
Australia
Phone: 61 8 9360 2888


Officers

Name Title
Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D. Exec. Chairman
Mr. Paul Frederick Anderson CEO, MD & Exec. Director
Ms. Leslie Wise J.D. Exec. Director
Ms. Nicole Jane Telford Chief Financial Officer
Mr. Alex McHenry Chief Operating Officer
Prof. Ming Hao Zheng Chief Scientific Officer and Member of Medical & Scientific Advisory Board
Mr. Simon Lee Robertson B.Bus, C.A., CA, M Appl. Fin. Company Sec.

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 8.6609
Price-to-Sales TTM: 52.1422
IPO Date:
Fiscal Year End: June
Full Time Employees: 0
Back to stocks